Altfest L J & CO Inc Pfizer Inc Transaction History

Altfest L J & CO Inc

$732 Million
Q2 2024

A detailed history of Altfest L J & CO Inc transactions in Pfizer Inc stock. As of the latest transaction made, Altfest L J & CO Inc holds 42,208 shares of PFE stock, worth $1.25 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

42,208

Previous 41,587 1.49%

Holding current value

$1.25 Million

Previous $1.15 Million 2.34%

% of portfolio

0.16%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$25.26 - $29.6 $15,686 - $18,381	621 Added 1.49%	42,208 $1.18 Million
Q1 2024 Apr 22, 2024	SELL	$25.89 - $29.73 $84,297 - $96,800	-3,256 Reduced 7.26%	41,587 $1.15 Million
Q4 2023 Jan 18, 2024	BUY	$26.13 - $33.94 $89,364 - $116,074	3,420 Added 8.26%	44,843 $1.29 Million
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $375,067 - $438,416	-11,688 Reduced 22.01%	41,423 $1.37 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $428,310 - $495,545	11,858 Added 28.74%	53,111 $1.95 Million
Q1 2023 Apr 20, 2023	SELL	$39.39 - $51.28 $15,243 - $19,845	-387 Reduced 0.93%	41,253 $1.68 Million
Q4 2022 Feb 02, 2023	BUY	$41.75 - $54.5 $4,717 - $6,158	113 Added 0.27%	41,640 $2.13 Million
Q3 2022 Nov 15, 2022	BUY	$43.76 - $53.42 $16,147 - $19,711	369 Added 0.9%	41,527 $1.82 Million
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $30,570 - $36,246	657 Added 1.62%	41,158 $2.16 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $65,422 - $81,066	-1,430 Reduced 3.41%	40,501 $2.1 Million
Q4 2021 Jan 24, 2022	SELL	$41.32 - $61.25 $572,943 - $849,292	-13,866 Reduced 24.85%	41,931 $2.48 Million
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $421,309 - $541,208	10,734 Added 23.82%	55,797 $2.4 Million
Q2 2021 Jul 28, 2021	SELL	$35.91 - $40.68 $56,917 - $64,477	-1,585 Reduced 3.4%	45,063 $1.77 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $48,794 - $55,030	1,457 Added 3.22%	46,648 $1.69 Million
Q4 2020 Jan 21, 2021	SELL	$33.47 - $42.56 $120,056 - $152,662	-3,587 Reduced 7.35%	45,191 $1.66 Million
Q3 2020 Oct 29, 2020	SELL	$31.75 - $37.25 $967,295 - $1.13 Million	-30,466 Reduced 38.45%	48,778 $1.79 Million
Q2 2020 Jul 21, 2020	BUY	$30.12 - $36.54 $384,993 - $467,054	12,782 Added 19.23%	79,244 $2.59 Million
Q1 2020 Apr 13, 2020	BUY	$27.03 - $38.62 $83,684 - $119,567	3,096 Added 4.89%	66,462 $2.17 Million
Q4 2019 Jan 06, 2020	BUY	$32.92 - $37.36 $194,590 - $220,834	5,911 Added 10.29%	63,366 $2.48 Million
Q3 2019 Oct 10, 2019	BUY	$32.49 - $42.13 $275,742 - $357,557	8,487 Added 17.33%	57,455 $2.06 Million
Q2 2019 Jul 15, 2019	SELL	$36.98 - $41.52 $536,394 - $602,247	-14,505 Reduced 22.85%	48,968 $2.12 Million
Q1 2019 Jun 10, 2019	SELL	$37.5 - $41.2 $412,537 - $453,241	-11,001 Reduced 14.77%	63,473 $2.7 Million
Q1 2019 May 24, 2019	SELL	$37.5 - $41.2 $5.28 Million - $5.8 Million	-140,689 Reduced 65.39%	74,474 $3.25 Million
Q1 2019 Apr 05, 2019	BUY	$37.5 - $41.2 $5.27 Million - $5.79 Million	140,641 Added 188.72%	215,163 $3.6 Million
Q4 2018 Jan 15, 2019	SELL	$38.47 - $43.86 $86,095 - $98,158	-2,238 Reduced 2.92%	74,522 $3.25 Million
Q3 2018 Oct 10, 2018	SELL	$34.47 - $41.81 $124,850 - $151,435	-3,622 Reduced 4.51%	76,760 $3.38 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $225,847 - $240,775	-6,848 Reduced 7.85%	80,382 $2.92 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $52,747 - $61,194	1,653 Added 1.93%	87,230 $3.1 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $663,137 - $703,612	-19,938 Reduced 18.9%	85,577 $3.1 Million
Q3 2017 Oct 23, 2017	BUY	$31.0 - $34.15 $3.27 Million - $3.6 Million	105,515	105,515 $3.77 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.

Account